Quantitative assessment of bone mineral density during estrogen replacement therapy

Gynecological Endocrinology

Volumn 13, Issue SUPPL. 6, 1999, Pages 29-34

  Thijssen, J H H ^b   Druckmann, R ^a  

^a Centre de Ménopause   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bone mineral density; Estrogen replacement therapy

Indexed keywords

BONE DENSITY; BONE MINERAL; CONFERENCE PAPER; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

AGE FACTORS; BONE DENSITY; DENSITOMETRY, X-RAY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SPINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033374774     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Thijssen JHH, Druckmann R. Effects of progestins on bone: an update. Gynecol Endocrinol 1999; 13(Suppl 4):25-39
2. Pouilles JM, Trémollieres F, Bonneu M, et al. Influence of early age at menopause on vertebral bone mass. J Bone Min Res 1994;9:311-5
3. Ribot C, Trémollieres F, Pouilles JM. Bone involvement in endocrinopathies. Presse Méd 1994;23:985-90
4. Ribot C, Trémollieres F, Pouilles JM. The effect of obesity on postmenopausal bone loss and the risk of osteoporosis. Adv Nutr Res 1994;9:257-71
5. Pouilles JM, Trémollieres F, Ribot C. Influence of body weight variations on the rate of bone loss at the beginning of menopause. Ann Endocrinol (Paris) 1995;56:585-9
6. Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass in adults. J Clin Invest 1987;80:706-10
7. Ralston SH. The genetics of osteoporosis. Q J Med 1997;90:247-51
8. Harris M, Nguyen TV, Howard GM, et al. Genetic and environmental correlations between bone formation and bone mineral density: a twin study. Bone 1998;22:141-5
9. Felson DT, Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. New Engl J Med 1993;329:1141-6
10. Draper MW, Flowers DE, Huster WJ, et al. A controlled trial of raloxifene (LY 139481) HCl: impact on bone turnover and serum lipid-profile in healthy postmenopausal women. J Bone Min Res 1996;11:835-42
11. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. J Am Med Assoc 1999;291:2189-97
12. Prestwood KM, Pilbeam CC, Woodiel FN, et al. The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 1994;79:366-71
13. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Am J Obstet Gynecol 1984;63:759-63
14. Writing Group for the PEPI trial. Effects of hormone therapy on bone mineral density. J Am Med Assoc 1996;276:1389-6
15. Genant HK, Lucas J, Weiss S, et al. Low-dose esterified estrogen therapy. Effects on bone, plasma estradiol concentrations, endometrium and lipid levels. Arch Intern Med 1997;157:2609-15
16. Williams SR, Frenchek B, Speroff T, et al. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. Am J Obstet Gynecol 1990; 162:438-46
17. Gallagher JC, Kable WT, Goldgar D. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 1991;90: 171-7
18. Mizunuma H, Okano H, Soda M, et al. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/ progestin therapy: a 2-year prospective study. Maturitas 1997;27:69-76
19. Grey AB, Cundy TF, Reid IR. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in postmenopausal women. Clin Endocrinol 1994;40:671-7
20. Wimalawansa SJ. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med 1998;104:219-26
21. Quigley MET, Martin PL, Burnier AM, et al. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987;156:1516-23
22. Prior JC, Vigna YM, Wark JD, et al. Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Min Res 1997;12:1851-63
23. Castelo-Branco C, Pons F, González J. Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry. Maturitas 1993;16:133-7
24. Nozaki M, Inoue Y, Hashimoto K, et al. Differential time-related effects of conjugated equine estrogen on bone metabolism in oophorectomized women. Int J Gynaecol Obstet 1998;60:41-6
25. Nozaki M, Hashimoto K, Inoue Y, et al. Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen. Int J Gynaecol Obstet 1998;62:69-75
26. Palacios S, Menéndez, Jurado AR, et al. Effects of percutaneous oestradiol versus oral oestrogens on bone density. Maturitas 1995;20:209-13